BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 28600705)

  • 1. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
    Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
    Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
    Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
    Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Liederbach E; Kyrillos A; Wang CH; Liu JC; Sturgis EM; Bhayani MK
    Int J Cancer; 2017 Feb; 140(3):504-512. PubMed ID: 27667729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
    Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
    Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
    Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
    Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
    Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients.
    Janz TA; Momin SR; Sterba KR; Kato MG; Armeson KE; Day TA
    Am J Otolaryngol; 2019; 40(1):40-45. PubMed ID: 30322742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA; Schiller JT
    Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of post-chemoradiotherapy DWI ADC
    Connor S; Sit C; Anjari M; Lei M; Guerrero-Urbano T; Szyszko T; Cook G; Bassett P; Goh V
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2323-2336. PubMed ID: 34159420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma.
    Windon MJ; D'Souza G; Waterboer T; Rooper L; Westra WH; Troy T; Pardoll D; Tan M; Yavvari S; Kiess AP; Miles B; Mydlarz WK; Ha PK; Bender N; Eisele DW; Fakhry C
    Head Neck; 2020 Aug; 42(8):1954-1962. PubMed ID: 32101350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
    Dave E; Su W; Gupta V; Miles B; Demicco E; Soriano T; Bakst RL
    Anticancer Res; 2017 Apr; 37(4):1847-1851. PubMed ID: 28373450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
    Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
    Menezes FDS; Latorre MDRDO; Conceição GMS; Curado MP; Antunes JLF; Toporcov TN
    PLoS One; 2020; 15(5):e0232871. PubMed ID: 32407339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.